Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-010049
Filing Date
2004-03-30
Accepted
2004-03-30 15:55:19
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2131537z10-k.htm 10-K 631991
3 EXHIBIT 10.56 a2131537zex-10_56.txt EX-10.56 7760
4 EXHIBIT 10.57 a2131537zex-10_57.txt EX-10.57 60440
5 EXHIBIT 10.58 a2131537zex-10_58.txt EX-10.58 53385
6 EXHIBIT 10.59 a2131537zex-10_59.txt EX-10.59 52258
7 EXHIBIT 10.60 a2131537zex-10_60.txt EX-10.60 56634
8 EXHIBIT 14.1 a2131537zex-14_1.htm EX-14.1 23233
9 EXHIBIT 23.1 a2131537zex-23_1.txt EX-23.1 644
10 EXHIBIT 31.1 a2131537zex-31_1.htm EX-31.1 5651
11 EXHIBIT 31.2 a2131537zex-31_2.htm EX-31.2 5676
12 EXHIBIT 32.1 a2131537zex-32_1.htm EX-32.1 3318
13 EXHIBIT 32.2 a2131537zex-32_2.htm EX-32.2 3315
  Complete submission text file 0001047469-04-010049.txt   907145
Mailing Address FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address FIVE SCIENCE PARK NEW HAVEN CT 06511 2037731450
GENAISSANCE PHARMACEUTICALS INC (Filer) CIK: 0001110009 (see all company filings)

EIN.: 061338846 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30981 | Film No.: 04700971
SIC: 8731 Services-Commercial Physical & Biological Research